TCI Wealth Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

TCI Wealth Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,766	Closed	-$56K	–	1665
2018 Q2	$56K	Hold	7,766	–	–	0.02%	300
2018 Q1	$47K	Hold	7,766	–	–	0.02%	343
2017 Q4	$75K	Sell	7,766 -1,750	-18%	-$11.5K	0.03%	278
2017 Q3	$85K	Sell	9,516 -2,000	-17%	-$20.6K	0.04%	233
2017 Q2	$146K	Sell	11,516 -2,250	-16%	-$26.6K	0.07%	166
2017 Q1	$145K	Hold	13,766	–	–	0.08%	174
2016 Q4	$127K	Buy	13,766 +10,221	+288%	+$115K	0.07%	195
2016 Q3	$42K	Hold	3,545	–	–	0.02%	323
2016 Q2	$46K	Buy	3,545 +15	+0.4%	+$219	0.03%	308
2016 Q1	$56K	Buy	3,530 +30	+0.9%	+$570	0.03%	286
2015 Q4	$100K	Hold	3,500	–	–	0.06%	207
2015 Q3	$100K	Hold	3,500	–	–	0.06%	195
2015 Q2	$126K	Hold	3,500	–	–	0.07%	174
2015 Q1	$102K	Buy	3,500 +2,672	+323%	+$70.7K	0.06%	171
2014 Q4	$17K	Buy	+828	New	+$16.4K	0.01%	372

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCI Wealth Advisors's INSY Position: Q3 2018 in Review

TCI Wealth Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q3 2018, closing a stake of 7,766 shares — an estimated $56K sold.

TCI Wealth Advisors first reported a position in INSY in Q4 2014 and held it in 15 quarters. The position peaked at $146K in Q2 2017. 110 funds tracked by Wall St. Rank hold INSY as of Q3 2018.

TCI Wealth Advisors reported no remaining Insys Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
TCI Wealth Advisors sold 7,766 Insys Therapeutics, Inc. shares in Q3 2018, an estimated $56K.
TCI Wealth Advisors first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 15 quarters.
TCI Wealth Advisors's Insys Therapeutics, Inc. position peaked at $146K in Q2 2017.
110 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2018.

Based on TCI Wealth Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.